Biosynthesis of the regulatory oxysterol, 5-cholesten-3β,25-diol 3-sulfate, in hepatocytes

Journal of Lipid Research

Volumn 48, Issue 12, 2007, Pages 2587-2596

  Li, Xiaobo ^a,c   Pandak, William M ^a   Erickson, Sandra K ^d   Ma, Yongjie ^a   Yin, Lianhua ^c   Hylemon, Phillip ^b   Ren, Shunlin ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

25 hydroxycholesterol; Cholesterol metabolism; Hydroxysteroid sulfotransferase; Mitochondria; Oxysterol metabolism; Oxysterol sulfation; Sterol 27 hydroxylase; Sulfated 25 hydroxycholesterol; Sulfated oxysterols

Indexed keywords

25 HYDROXYCHOLESTEROL; 3' PHOSPHOADENOSYL 5' PHOSPHOSULFATE; 5 CHOLESTEN 3BETA,25 DIOL 3 SULFATE; CHOLESTANETRIOL 26 MONOOXYGENASE; HYDROXYCHOLESTEROL SULFOTRANSFERASE 2B1B; MESSENGER RNA; OXYSTEROL; SMALL INTERFERING RNA; STEROL 27 HYDROXYLASE; SULFATE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; HOMEOSTASIS; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP27A1; CYTOSOL; HEPATOCYTES; HUMANS; HYDROXYCHOLESTEROLS; MICE; MICE, KNOCKOUT; RATS; SULFOTRANSFERASES; SULFURIC ACID ESTERS; TRANSFECTION;

EID: 37249016419     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700301-JLR200     Document Type: Article

References (35)

1. Pandak, W. M., D. M. Heuman, P. B. Hylemon, and Z. R. Vlahcevic. 1990. Regulation of bile acid synthesis. IV. Interrelationship between cholesterol and bile acid biosynthesis pathways. J. Lipid Res. 31: 79-90.
2. Chiang, J. Y. 2003. Bile acid regulation of hepatic physiology. III. Bile acids and nuclear receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G349-G356.
3. Hylemon, P. B., R. T. Stravitz, and Z. R. Vlahcevic. 1994. Molecular genetics and regulation of bile acid biosynthesis. Prog. Liver Dis. 12: 99-120.
4. Goodwin, B., M. A. Watson, H. Kim, J. Miao, J. K. Kemper, and S. A. Kliewer. 2003. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol. Endocrinol. 17: 386-394.
5. Pandak, W. M., S. Ren, D. Marques, E. Hall, K. Redford, D. Mallonee, P. Bohdan, D. Heuman, G. Gil, and P. Hylemon. 2002. Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. J. Biol. Chem. 277: 48158-48164.
6. Ren, S., P. B. Hylemon, D. Marques, E. Gurley, P. Bodhan, E. Hall, K. Redford, G. Gil, and W. M. Pandak. 2004. Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse. Hepatology. 40: 910-917.
7. Dubrac, S., S. R. Lear, M. Ananthanarayanan, N. Balasubramaniyan, J. Bollineni, S. Shefer, H. Hyogo, D. E. Cohen, P. J. Blanche, R. M. Krauss, et al. 2005. Role of CYP27A in cholesterol and bile acid metabolism. J. Lipid Res. 46: 76-85.
8. Li, X., P. Hylemon, W. M. Pandak, and S. Ren. 2006. Enzyme activity assay for cholesterol 27-hydroxylase in mitochondria. J. Lipid Res. 47: 1507-1512.
9. Adams, C. M., J. Reitz, J. K. De Brabander, J. D. Feramisco, L. Li, M. S. Brown, and J. L. Goldstein. 2004. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279: 52772-52780.
10. Bjorkhem, I., and U. Diczfalusy. 2002. Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. Biol. 22: 734-742.
11. Corsini, A., D. Verri, M. Raiteri, P. Quarato, R. Paoletti, and R. Fumagalli. 1995. Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler. Thromb. Vasc. Biol. 15: 420-428.
12. Fu, X., J. G. Menke, Y. Chen, G. Zhou, K. L. Macnaul, S. D. Wright, C. P. Sparrow, and E. G. Lund. 2001. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276: 38378-38387.
13. Javitt, N. B. 2002. Cholesterol, hydroxycholesterols, and bile acids. Biochem. Biophys. Res. Commun. 292: 1147-1153.
14. Meir, K., D. Kitsberg, I. Alkalay, F. Szafer, H. Rosen, S. Shpitzen, L. B. Avi, B. Staels, C. Fievet, V. Meiner, et al. 2002. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J. Biol. Chem. 277: 34036-34041.
15. Ren, S., P. Hylemon, Z. P. Zhang, D. Rodriguez-Agudo, D. Marques, X. Li, H. Zhou, G. Gil, and W. M. Pandak. 2006. Identification of a novel sulfonated oxysterol, 5-cholesten-3beta,25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria. J. Lipid Res. 47: 1081-1090.
16. Ren, S., X. Li, D. Rodriguez-Agudo, G. Gil, P. Hylemon, and W. M. Pandak. 2007. Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes. Biochem. Biophys. Res. Commun. 360: 802-808.
17. Lund, E., I. Bjorkhem, C. Furster, and K. Wikvall. 1993. 24-, 25-and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta. 1166: 177-182.
18. Aksoy, I. A., D. M. Otterness, and R. M. Weinshilboum. 1993. Cholesterol sulfation in human liver. Catalysis by dehydroepiandrosterone sulfotransferase. Drug Metab. Dispos. 21: 268-276.
19. Falany, C. N., D. He, N. Dumas, A. R. Frost, and J. L. Falany. 2006. Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization. J. Steroid Biochem. Mol. Biol. 102: 214-221.
20. Higashi, Y., H. Fuda, H. Yanai, Y. Lee, T. Fukushige, T. Kanzaki, and C. A. Strott. 2004. Expression of cholesterol sulfotransferase (SULT2B1b) in human skin and primary cultures of human epidermal keratinocytes. J. Invest. Dermatol. 122: 1207-1213.
21. Fuda, H., N. B. Javitt, K. Mitamura, S. Ikegawa, and C. A. Strott. 2007. Oxysterols are substrates for cholesterol sulfotransferase. J. Lipid Res. 48: 1343-1352.
22. Javitt, N. B., Y. C. Lee, C. Shimizu, H. Fuda, and C. A. Strott. 2001. Cholesterol and hydroxycholesterol sulfotransferases: identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology. 142: 2978-2984.
23. Liu, L., E. L. LeCluyse, J. Liu, and C. D. Klaassen. 1996. Sulfotransferase gene expression in primary cultures of rat hepatocytes. Biochem. Pharmacol. 52: 1621-1630.
24. Watabe, T., K. Ogura, M. Satsukawa, H. Okuda, and A. Hiratsuka. 1994. Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chem. Biol. Interact. 92: 87-105.
25. He, D., A. R. Frost, and C. N. Falany. 2005. Identification and immunohistochemical localization of sulfotransferase 2B1b (SULT2B1b) in human lung. Biochim. Biophys. Acta. 1724: 119-126.
26. Chen, W., G. Chen, D. L. Head, D. J. Mangelsdorf, and D. W. Russell. 2007. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5: 73-79.
27. Hylemon, P. B., E. C. Gurley, R. T. Stravitz, J. S. Litz, W. M. Pandak, J. Y. Chiang, and Z. R. Vlahcevic. 1992. Hormonal regulation of cholesterol 7 alpha-hydroxylase mRNA levels and transcriptional activity in primary rat hepatocyte cultures. J. Biol. Chem. 267: 16866-16871.
28. Ren, S., P. Hylemon, D. Marques, E. Hall, K. Redford, G. Gil, and W. M. Pandak. 2004. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J. Lipid Res. 45: 2123-2131.
29. Babiker, A., O. Andersson, E. Lund, R. J. Xiu, S. Deeb, A. Reshef, E. Leitersdorf, U. Diczfalusy, and I. Bjorkhem. 1997. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272: 26253-26261.
30. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131.
31. Saucier, S. E., A. A. Kandutsch, F. R. Taylor, T. A. Spencer, S. Phirwa, and A. K. Gayen. 1985. Identification of regulatory oxysterols, 24(S),25-epoxycholesterol and 25-hydroxycholesterol, in cultured fibroblasts. J. Biol. Chem. 260: 14571-14579.
32. Kohjitani, A., H. Fuda, O. Hanyu, and C. A. Strott. 2006. Cloning, characterization and tissue expression of rat SULT2B1a and SULT2B1b steroid/sterol sulfotransferase isoforms: divergence of the rat SULT2B1 gene structure from orthologous human and mouse genes. Gene. 367: 66-73.
33. Meloche, C. A., and C. N. Falany. 2001. Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b). J. Steroid Biochem. Mol. Biol. 77: 261-269.
34. Cui, D., C. L. Booth-Genthe, E. Carlini, B. Carr, and M. L. Schrag. 2004. Heterotropic modulation of sulfotransferase 2A1 activity by celecoxib: product ratio switching of ethynylestradiol sulfation. Drug Metab. Dispos. 32: 1260-1264.
35. Wong, C. K., and W. M. Keung. 1997. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem. Biophys. Res. Commun. 233: 579-583.